Indian Healthcare - New Avenues for Growth

India represents one of the most rapidly emerging healthcare products and services market in the world, with the worth of around US$ 45.8 Billion in 2009. Moreover, the industry has successfully been able to survive amid global financial turmoil owing to prevalence of chronic as well as communicable diseases, among which the most recent is Swine Flu.

According to our newly updated research report “Indian Healthcare - New Avenues for Growth”, the potentials of the Indian healthcare industry are immense and it is expected to rise exponentially owing to increasing per capita healthcare spending and deliberate investments in this sector by the private players. It is expected that this market will grow at a CAGR of around 21% during 2010-2013. The growth of the healthcare market will mainly by driven by factors such as changing demographics profile, epidemiological transitions and increasing health insurance penetration. Our report discusses about all such key drivers that are stimulating growth in the healthcare market.

India represents the second most populated country in the world. Our research finds that with a rapidly expanding economy and increasing urbanization, prevalence of a number of chronic diseases, such as cardiovascular, diabetes, arthritis and cancer, will increase rapidly in India. In addition to this, our report also explores that sectors such as medical tourism market and pharma outsourcing market will grow at a CAGR of around 31% and 34% respectively during 2010-2013. So, the country is well-poised to become a source of opportunities for players operating in these segments.

“Indian Healthcare - New Avenues for Growth” contains unique industry research and provides a detailed and objective analysis on the Indian healthcare market. It acquaints clients with statistical and analytical overview of the Indian healthcare market coupled with past, present and future forecast till 2013 on the entire composition and functioning of the Indian healthcare sector. Forecast in this research has been done judiciously, considering the possible post-recession impacts on the industry. It also studies a number of related sectors such as hospital services, pharmaceuticals, medical devices, outsourcing services, medical tourism, infrastructure, medical textiles and path labs.

All-in-all, the research report will help clients to have proper insight of the Indian healthcare market’s current and future performance. It will thus be a valuable asset for the new market entrants as it will help them in framing their strategies accordingly.
[Studien Infos ausblenden]

1. Analyst View
2. The Indian Healthcare Market
2.1 Healthcare Indicators & Demographics
2.1.1 Healthcare Spending
2.1.2 Source of Funding
2.1.3 Demographics
2.1.4 Healthcare Institutions
2.1.5 Healthcare Professionals
2.1.6 Leading Causes of Death
3. Key Market Drivers
3.1 Population
3.2 Epidemiological Transitions
3.3 Rising Income
3.4 Increasing Health Insurance Penetration
3.5 Improving Medical Infrastructure
4. Emerging Sectors to 2013
4.1 Hospital Services
4.2 Pharmaceuticals
4.3 Medical Tourism
4.4 Medical Infrastructure
4.5 Medical Devices
4.6 Pharma Outsourcing
4.7 Healthcare Outsourcing
4.8 Path Labs
4.9 Medical Textiles
4.10 Health Insurance
4.11 Healthcare Training & Education Services
4.12 Clinical Trials
5. Analysis by Disease Type
5.1 Cardiovascular
5.2 Diabetes
5.3 Oncology
5.4 HIV
5.5 IVD
6. Industry Restraints
6.1 Affordability & Accessibility
6.2 Government Support
6.3 Lack of Standardization
6.4 Currency Fluctuations
[Inhaltsverzeichnis ausblenden]

Figure 2-1: Healthcare Market (Billion US$), 2008 & 2009
Figure 2-2: Forecast for Healthcare Market (Billion US$), 2010-2013
Figure 2-3: Healthcare Spending (Billion US$), 2004-2009
Figure 2-4: Forecast for Healthcare Spending (Billion US$), 2010-2013
Figure 2-5: Healthcare Payment by Source (%)
Figure 2-6: Life Expectancy (Years), 2001-2009
Figure 2-7: Forecast for Life Expectancy (Years), 2010-2013
Figure 2-8: Population Breakup by Gender (%), 2003-2006
Figure 2-9: Population Breakup by Age Group (%), 2004-2009
Figure 2-10: Forecast for Population Breakup by Age Group (%), 2010-2013
Figure 2-11: Number of Doctors (‘000), 2007-2009
Figure 2-12: Forecast for Number of Doctors (‘000), 2010-2013
Figure 2-13: Number of Nurses (‘000), 2006-2009
Figure 2-14: Forecast for Number of Nurses (‘000), 2010-2013
Figure 2-15: Leading Causes of Death (%), 2005
Figure 2-16: Forecast for Leading Causes of Death (%), 2030
Figure 3-1: Population (Billion), 2002-2009
Figure 3-2: Forecast for Population (Billion), 2010-2013
Figure 3-3: Prevalence of various Lifestyle-related Diseases (Million), 2005 & 2015
Figure 3-4: Per Head Personal Disposable Income (US$), 2006-2009
Figure 4-1: Hospital Bed Revenues (Billion US$), 2006-2009
Figure 4-2: Forecast for Hospital Bed Revenues (Billion US$), 2010-2013
Figure 4-3: Hospitalization Cases by Type of Diseases (%), 2008
Figure 4-4: Bed Occupancy Rate (%)
Figure 4-5: Domestic Pharmaceutical Market (Billion INR), FY 2007 to FY 2009
Figure 4-6: Domestic Pharmaceutical Market by Drug Category (%), 2005
Figure 4-7: Forecast for Domestic Pharmaceutical Market by Drug Category (%), 2010
Figure 4-8: Domestic Pharmaceutical Market by Therapeutic Category (%), 2008
Figure 4-9: Forecast for Domestic Pharmaceutical Market (Billion INR), FY 2010 to FY 2013
Figure 4-10: Medical Tourist Arrivals (‘000), 2007-2013
Figure 4-11: Forecast for Medical Tourism Market (Billion INR), 2010-2013
Figure 4-12: Medical Infrastructure Market (Billion US$), 2006-2009
Figure 4-13: Medical Infrastructure Market by Segment (%), 2008
Figure 4-14: Number of Beds (per 1000 Population), 2008 & 2012
Figure 4-15: Healthcare Floor Space (Million Sq. ft), FY 2008 & FY 2018
Figure 4-16: Healthcare Land Area (Acre), FY 2008 & FY 2018
Figure 4-17: Medical Infrastructure Investment (Million US$), 2006 & 2009
Figure 4-18: Forecast for Medical Infrastructure Market (Billion US$), 2010-2013
Figure 4-19: Medical Devices Market (Billion US$), 2006-2013
Figure 4-20: Medical Devices Export and Import (Million US$), 2007 & 2008
Figure 4-21: Medical Devices Market by Type (%)
Figure 4-22: Pharma Outsourcing Market (Million US$), 2004, 2006-2009
Figure 4-23: Pharma Outsourcing Market by Segment (%), 2006
Figure 4-24: Forecast for Pharma Outsourcing Market (Million US$), 2010-2013
Figure 4-25: Forecast for Pharma Outsourcing Market by Segment (%), 2011
Figure 4-26: Healthcare Outsourcing Market (Billion US$), 2006-2013
Figure 4-27: Independent Path Lab Market (Billion US$), 2006-2013
Figure 4-28: Classification of Medical Textiles
Figure 4-29: Medical Textiles Market (Million US$), 2006-2013
Figure 4-30: Forecast for Medical Textiles Market by Segment (%), FY 2010
Figure 4-31: Health Insurance Market (Billion INR), FY 2002 to FY 2009
Figure 4-32: Health Insurance Market by Segment (%), FY 2009
Figure 4-33: Share of Major Companies in Health Insurance Market (FY 2008)
Figure 4-34: Forecast for Health Insurance Market (Billion INR), FY 2010 to FY 2013
Figure 4-35: Forecast for Doctors Demand (‘000), 2010-2013
Figure 4-36: Healthcare Training & Education Services Market (Billion US$), 2006-2012
Figure 4-37: Number of Clinical Trials (2007-2009)
Figure 4-38: Forecast for Number of Clinical Trials (2010-2012)
Figure 4-39: Clinical Research Market (Million US$), 2007-2009
Figure 4-40: Forecast for Clinical Research Market (Million US$), 2010-2012
Figure 5-1: Number of Coronary Heart Patients (Million), 2005 & 2015
Figure 5-2: Cardiac Drugs Market (Billion INR), 2006-2009
Figure 5-3: Forecast for Cardiac Drugs Market (Billion INR), 2010-2013
Figure 5-4: Number of Diabetic Patients (Million), 2009 & 2010
Figure 5-5: Diabetes Market (Billion INR), 2006-2013
Figure 5-6: New & Total Number of Cancer Patients (Million)
Figure 5-7: Cancer Drugs Market (Million US$), 2007 & 2012
Figure 5-8: Prevalence of HIV (%), 2002 & 2008
Figure 5-9: Antiretroviral Market (Million INR), 2006, 2007 & 2012
Figure 5-10: IVD Market (Million US$), 2007-2009
Figure 5-11: IVD Market by Segment (%), 2007
Figure 5-12: Forecast for IVD Market (Million US$), 2010-2013
Figure 6-1: Per Capita Healthcare Spending w.r.t Other Major Countries (US$), 2007
Figure 6-2: Global - Share of State & Personal Financing in Top Pharmaceutical Markets (2006)

Table 4-1: Cost of Various Surgical Procedures w.r.t. Other Countries (US$), 2009
[Tabellenverzeichnis ausblenden]